Skip to main content

Table 3 Most common prescription medications filled in non-VHA pharmacies by dual enrolled patients, FY10

From: Pharmacy use by dual-eligible non-elderly veterans with private healthcare insurance

  

Pharmacy user status

 

Medicationa

All patients

N = 3773

n (%)

Dual users

N = 1683

n (%)

Non-VHA only users

N = 2935

n (%)

Statistics: dual vs. non-VHA only users

X2; DF; p

Hydrocodone

963 (20.9)

347 (20.6)

616 (21.0)

.09; 1; .766

Amoxicillin

853 (18.5)

338 (20.1)

515 (17.6)

4.6; 1; .033

Simvastatin

809 (17.5)

180 (10.7)

629 (21.4)

85; 1; <.001b

Azithromycin

802 (17.4)

304 (18.1)

498 (17.0)

.89; 1; .344

Lisinopril

699 (15.1)

185 (11.0)

514 (17.5)

35; 1; <.001b

Omeprazole/esomeprazole

477 (10.3)

127 (7.6)

350 (11.9)

22; 1; <.001b

Prednisone

429 (9.3)

173 (10.3)

256 (8.7)

3.1; 1; .079

Cephalexin

422 (9.1)

172 (10.2)

250 (8.5)

3.7; 1; .053

Metoprolol

391 (8.5)

105 (6.2)

286 (9.7)

17; 1; <.001b

Hydrochlorothiazide

374 (8.1)

92 (5.5)

282 (9.6)

25; 1; <.001b

Metformin

338 (7.3)

82 (4.9)

256 (8.7)

23; 1; <.001b

Ciprofloxacin

313 (6.8)

129 (7.7)

184 (6.3)

3.3; 1; .069

Levofloxacin

292 (6.3)

118 (7.0)

174 (5.9)

2.1; 1; .146

Cyclobenzaprine

289 (6.3)

88 (5.2)

201 (6.9)

4.8; 1; .029

Atorvastatin

243 (5.3)

41 (2.4)

202 (6.9)

42; 1; <.001b

  1. aIncludes all single agent and combination products that contain the ingredient medication (e.g. lisinopril includes combination formulations with other active ingredients such as hydrochlorothiazide; amoxicillin includes amoxicillin plus clavulanate combination products). Cell counts represent the number of unique patients who received each medication during FY10
  2. bStatistically significant difference based on Bonferroni correction for multiple comparisons (α = 0.0033)